Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03169842 · ClinicalTrials.gov registry record · NA
Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts
A NA study of Pancreatic Cyst, sponsored by Ochsner Health System.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03169842 is a NA study of Pancreatic Cyst that has completed, run by Ochsner Health System. The registered enrollment target is 37 participants, below the 548-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03169842, a NA study of Pancreatic Cyst, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the utility of using cyst fluid glucose levels to diagnose mucinous pancreatic cysts during endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) procedures.
Conditions Studied
Interventions
- DEVICE pancreatic cyst fluid glucose analysis using a bedside glucometer
Study Locations (1)
Louisiana
- Ochsner Medical Center - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-05-25 |
| Est. Completion | 2022-04-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03169842
The ClinicalTrials.gov registry entry for NCT03169842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 548-participant average among 18 other Pancreatic Cyst trials with a reported enrollment target (93% lower). The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Cyst appearing as the primary indexed condition, and to 1 intervention - of which pancreatic cyst fluid glucose analysis using a bedside glucometer is the first listed.
NCT03169842 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT03169842 about?
NCT03169842 is a clinical study titled "Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts". This study evaluates the utility of using cyst fluid glucose levels to diagnose mucinous pancreatic cysts during endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) procedures.
What is the current status of trial NCT03169842?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-05-25. Estimated completion is 2022-04-18.
What conditions does trial NCT03169842 study?
This clinical trial studies the following conditions: Pancreatic Cyst.
What interventions are being tested in trial NCT03169842?
The interventions under investigation include: pancreatic cyst fluid glucose analysis using a bedside glucometer (DEVICE).
Who is sponsoring clinical trial NCT03169842?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03169842 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cyst
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies
RECRUITING · NA
-
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts
COMPLETED · NA
-
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms
RECRUITING
-
UCSF PANC Cyst Registry
RECRUITING
-
PROMs After Pancreatectomy
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.